Abstract:148 Frontline Therapy with the RiBVD Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final…

New Evidence reports on presentations given at ASH 2010 Rituximab in the Treatment of NHL: Rituximab versus Watch and Wait in Asymptomatic FL, R-Maintenance Therapy in FL…

Jonathan W Friedberg, MD, MMSc Associate Professor of Medicine and Hematology Chief, Hematology/Oncology Division James P Wilmot Cancer Center University of Rochester Rochester,…

An Update on the Treatment of Lymphoma Ted Wun, M.D., F.A.C.P. Professor of Medicine and Chief In consultation with Joseph Tuscano, M.D. Professor of Medcine Division of…

Marinus van Oers Professor of Hematology/Head of the Department of Clinical Hematology, Academic Medical Center, University of Amsterdam, The Netherlands Chairman of the…

Treatment of non-Hodgkin Lymphomas Over 40 different types of NHL: reflection of the complex growth and differentatition of normal (B) lymphocytes Treatment of non-Hodgkin…